Table 3.
Effectiveness of Cissus quadrangularis formulation on serological characteristics: Percent difference in means from Week 0 to Week 8
| BMI | Greater than 30 (Obese) | 25 – 29 (Overweight) | ||
| Treatment | Placebo (n = 30) | Formulation/no diet (n = 31) | Formulation/Diet (n = 31) | Formulation/no diet (n = 31) |
| Serological Characteristics* | ||||
| Total Cholesterol (%) | -3.1 (28.7) | -27.0 (14.6)a | -26.0 (13.3)a | -18.8 (17.0)b |
| LDL Cholesterol (%) | -10.4 (13.4) | -18.4 (9.8)c | -32.4 (15.5)a | -26.4 (12.8)a |
| HDL Cholesterol (%) | 17.4 (38.8) | 50.5 (50.7)b | 43.0 (39.5)c | 19.6 (37.0) |
| Triglycerides (%) | -4.5 (25.4) | -36.8 (17.8)a | -28.0 (12.2)a | -15.0 (15.3)c |
| C-Reactive Protein (%) | 0.8 (13.2) | -20.8 (11.2)a | -20.8 (10.0)a | -16.3 (13.2)a |
| Fasting Blood Glucose (%) | -4.6 (14.8) | -13.4 (13.6)b | -16.1 (13.4)a | -11.4 (11.8)c |
* These data are shown as means with standard deviations in parentheses
a P = <0.001 versus placebo
b P = <0.01 versus placebo
c P = <0.05 versus placebo